Bavituximab Completed Phase 1 Trials for Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00129337Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies